Global Wireless Charging Leader Aircharge Confirms Certified Wireless Charging Compatibility with the New iPhone 8/8 Plus and iPhone X Models
Aircharge, the global leader in wireless charging solutions for public venues, the office and home, has confirmed today full compatibility with the newly announced iPhone 8/8 Plus and iPhone X models. Both Aircharge and Apple utilise the universal standard for wireless charging of smartphones and other consumer electronic devices, Qi.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170913005621/en/
The new iPhone X is fully compatible with the Aircharge solution (Photo: Business Wire)
Aircharge is the world’s largest deployer of wireless charging facilities in public venues and via the Aircharge Locator app provides access to 5,000 locations globally including restaurants, cafes, shops, hotels, airports and train stations.
Aircharge offers a safe and convenient method of bringing wireless power to a surface or table-top, enabling any smartphone to charge wirelessly. Owners of the new iPhone X, 8 and 8 Plus models will be able to charge their devices by simply placing them on the Aircharge surface charger. Previous iPhone models without the built-in wireless charging capabilities, are also able to charge thanks to the use of the Aircharge “Orb”- the world’s first and only multi-head connector carrying both the Qi and Made for iPhone (MFi) certifications and allowing any Lightning, Micro-USB and USB Type-C devices to charge from the charging unit.
“We’re a long time partner of Apple via its MFi program and we’re excited Qi wireless charging is now a standard feature in the new iPhone models. The inclusion of wireless charging from a major mobile phone and tech manufacturer like Apple will accelerate and drive widespread consumer awareness and mainstream adoption”, said Steven Liquorish, founder and CEO of Aircharge.
Globally renowned brands like McDonald’s, Starbucks, YO! Sushi, Costa Coffee and Vapiano are among the first to deploy Aircharge in their venues, enabling their customers to top up whilst enjoying a meal or refreshment. McDonald’s, the largest provider to date, currently include the service at more than 400 UK stores and has begun deployment in 14 regions.
In addition, Aircharge provides wireless charging at Virgin Atlantic Clubhouses in Heathrow and Gatwick airport, Emirates Lounges in Dubai International and Finnair Lounges in Helsinki-Vantaa. Eurostar offers Aircharge wireless charging to their customers visiting their Business Premier Lounges in London St Pancras International and Paris Gare du Nord. Virgin Trains has deployed across its First Class lounges along the East and West coast routes in the UK. Hotels offering Aircharge include Premier Inn, IBIS and Novotel. Aircharge is also available in major mobile network carriers, including Vodafone, O2 and EE, as a complimentary service for customers visiting their retail stores, and in leisure centers like Virgin Active Health Clubs.
Founded in 2013, Aircharge’s vision is to allow users to charge their mobile devices wirelessly throughout the course of the day, without the need for carrying a wire or battery pack. “As we have all become increasingly dependent on mobile devices, we now likely require to charge the battery more than once per day with the challenge of finding accessible power sources when on the go. By using the Aircharge Locator app, users can easily navigate to the nearest Aircharge point to get instant, free power”, added Mr. Liquorish.
London is currently the first unique global wireless charging hub, providing a city-wide deployment of public charging point. 1,100 locations are now available in the UK, with more coming also in Europe, US and rest of the World. Aircharge is also an official partner of BMW, Mercedes-Benz and Lexus and offers accessories and solutions for the car, home and office and it is the only brand to offer a full range of Made for iPhone certified wireless charging cases for non-Qi iPhone models.
With now more than 90 Qi certified models of smartphones, 80 models of cars and over 900 wireless charging accessories available on the market, the Aircharge ecosystem is only expected to grow further.
For more information, please visit:
Aircharge Media Relations
+44 (0)1235 773 37
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31 | Pressemelding
Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00 | Pressemelding
AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20 | Pressemelding
AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11 | Pressemelding
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20 | Pressemelding
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31 | Pressemelding
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom